Outcomes of switching directly to oral fingolimod from injectable therapies: Results of the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis - Fox, E; Edwards, K; Burch, G (Mult Scler Relat Dis, 2014)
et al.